Personalis ROE 2018-2024 | PSNL

Current and historical return on equity (ROE) values for Personalis (PSNL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Personalis ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $-0.09B $0.17B -69.57%
2024-06-30 $-0.08B $0.11B -63.94%
2024-03-31 $-0.09B $0.12B -64.47%
2023-12-31 $-0.11B $0.13B -67.08%
2023-09-30 $-0.11B $0.15B -61.16%
2023-06-30 $-0.11B $0.18B -53.01%
2023-03-31 $-0.11B $0.19B -49.62%
2022-12-31 $-0.11B $0.22B -44.66%
2022-09-30 $-0.10B $0.24B -36.96%
2022-06-30 $-0.09B $0.27B -31.68%
2022-03-31 $-0.08B $0.29B -25.69%
2021-12-31 $-0.07B $0.31B -19.67%
2021-09-30 $-0.06B $0.33B -19.22%
2021-06-30 $-0.05B $0.34B -18.42%
2021-03-31 $-0.04B $0.35B -20.95%
2020-12-31 $-0.04B $0.20B -27.75%
2020-09-30 $-0.04B $0.20B -27.83%
2020-06-30 $-0.03B $0.09B -31.22%
2020-03-31 $-0.03B $0.10B -26.73%
2019-12-31 $-0.03B $0.11B -31.04%
2019-06-30 $-0.02B $0.12B -54.70%
2019-03-31 $-0.02B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.261B $0.073B
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00